SEC 13F Intelligence

Mpm Bioimpact LLC / EVMN

Mpm Bioimpact LLC’s Evommune Inc Position

Does Mpm Bioimpact LLC own Evommune Inc (EVMN)? Yes1.46M shares worth $33M (+2.58% of its 13F portfolio) as of Q1 2026, up from 113.0K shares the prior filed quarter.

Position Value
$33M
Q1 2026
Shares
1.46M
% of Portfolio
+2.58%
Quarters Held
2
currently held

Position History EVMN

Reported value by quarter
Q4 ’25: $2MQ4 ’25Q1 ’26: $33MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.46M$33M+2.58%
Q4 2025113.0K$2M+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of EVMN.